INS Presidential Invitational Webinar: Cognitive Effects of Epilepsy and Its Treatments

Current Status
Ended
Price
$100.00
Course ended

The International Neuropsychological Society (INS) is approved by the American Psychological Association to sponsor continuing education for psychologists. The INS maintains responsibility for this program and its content. The International Neuropsychological Society, Inc. is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0154.

Course Information

Target Audience Advanced
CE Credit(s)
1.0 hour (1 credit)
Cost
  • INS Members: $20*
  • Non-Members: $30
  • *INS members may watch the webinar FREE and/or pay for optional CE credit
Availability
  • Date of Live Webinar:  November 25, 2025
  • Availability:  The on-demand course will be available 24-48 hours after the live webinar concludes. To ensure relevancy, CE courses are generally available for 3 years.
  • Refund Policy:  This webinar is not eligible for refunds. After watching the webinar, participants will have two attempts to pass a quiz on their learning. If the quiz is not passed after two attempts, participants may re-purchase the test and try again.

Current INS members may watch the webinar for free. CE credit is optional and may be purchased for an additional fee. Non-members must purchase the CE course to watch the webinar and receive CE credit (or apply to become a member and watch for free without purchasing CE).

Synopsis

Cognitive problems are common in people with epilepsy. Multiple factors contribute to these cognitive impairments. This webinar will discuss how these factors contribute including the risk of epilepsy treatments. Understanding of these factors is needed in order to assess and manage this population of patients appropriately.

Learning Objectives

People with epilepsy have increased risk for cognitive impairments, which are due to multiple factors. Neuropsychologist and physicians need to be aware of how these factors contribute including the risk of epilepsy treatments in order to assess and manage this population of patients appropriately. This webinar is designed to help attendees:

  1. Understand the factors including treatments which contribute to cognitive impairments in people with epilepsy.
  2. Understand our current knowledge of the differential risks for poor neurodevelopmental outcomes due to fetal antiseizure medication exposures.

Speaker

Kimford J. Meador, MD, FAAN, FAES, FRCPE

Kimford J. Meador, MD, FAAN, FAES, FRCPE

Professor of Neurology & Neurological Sciences
Stanford University Palo Alto, California, USA

Kimford J. Meador, MD, FAAN, FAES, FRCPE is Professor of Neurology & Neurosciences at Stanford University. He has authored 487 peer-reviewed articles, which are predominately related to neuropsychological brain mechanisms, epilepsy, and the neuropsychological effects of epilepsy and its treatments. Dr. Meador has directed a long running NIH multicenter study of pregnancy outcomes in women with epilepsy and their children. Among his honors are American Academy of Neurology past section chairs for Behavioral Neurology and for Epilepsy; American Epilepsy Society Clinical Research Award; named award for him for research in women with epilepsy; ranked in the top 0.017% of published authors worldwide on epilepsy 2013 - 2023 by Expertscape; and ranked in the top neuroscientist (#563 in the world and #318 in United States) by Research.com in 2023.

Disclosures

Dr. Meador receives grant and salary support paid to his institution for contracted research from the National Institutes of Health (NIH), Medtronic Inc., and Eisai Inc. The non-profit Epilepsy Study Consortium pays Dr. Meador’s university a set amount for direction of the Cognitive Core of the Human Epilepsy Project and for consultant work for the Epilepsy Study Consortium related to the following companies in the last 3 years: Eisai, Xenon and UCB Pharma.

References

  • Li, Y & Meador, K.J. (2022). Epilepsy and Pregnancy. Continuum (Minneap Minn), 28(1), 34-54. doi: 10.1212/CON.0000000000001056. PMID: 35133310.
  • Meador, K.J. (2020). Cognitive effects of epilepsy and its treatments, Chapter 93 (pp. 1058-63). In: Wyllie E, Gidal BE, Goodkin HP, Jehi L, Loddenkemper T (Eds). Wyllie’s Treatment of Epilepsy: Principles & Practice, 7th Edition. Philadelphia: Lippincott Williams & Wilkins. (Note that 8th edition will be published soon).
  • Meador, K.J. (2022). Effects of Maternal Use of Antiseizure Medications on Child Development. Neurol Clin, 40(4), 755-768. doi: 10.1016/j.ncl.2022.03.006. Epub 2022 Sep 28. PMID: 36270689.

Current INS members may watch the webinar for free. CE credit is optional and may be purchased for an additional fee. Non-members must purchase the CE course to watch the webinar and receive CE credit (or apply to become a member and watch for free without purchasing CE).